Gene · 389421
NIH grants1,664
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,664
Download this page as JSON| Grant | Title | LIN28B papers | Newest fiscal year |
|---|---|---|---|
| R01EY030989 | Molecular Determinants for WDR5-Driven Transcriptional Regulation at Lineage-Specifying Genes During Retinogenesis | 1 | 2024 |
| R01EY031054 | Neuroprotective Role of Sirt6 in Glaucoma | 1 | 2024 |
| R01EY032542 | 3D visualization and Investigation of Retinal Axon Regeneration | 1 | 2024 |
| R01GM067945 | New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin Biology | 1 | 2024 |
| R01GM073981 | RNA trafficking in mitochondria | 1 | 2024 |
| R01GM123139 | Coupling of Protein Synthesis with Cell Division | 1 | 2024 |
| R01GM140456 | Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome | 1 | 2024 |
| R01HD101669 | Integrating genomic studies of gestational duration and birth weight to understand maternal and fetal causes of adverse pregnancy outcomes and links with later diseases | 1 | 2024 |
| R01HG011207 | Computational methods to identify neo-TADs and enhancer-hijacking in rearranged genomes | 1 | 2024 |
| R01HL153487 | Understanding the role of stellate cells in the liver hematopoietic stem cell niche | 1 | 2024 |
| R01HL155868 | Understanding and targeting bone marrow microenvironment in myelofibrosis | 1 | 2024 |
| R01HL162408 | MYCT1 as a moderator for signaling between human HSC and their niche | 1 | 2024 |
| R01NS113763 | Molecular Segregation of Parkinson’s Disease by Patient-Derived Neurons | 1 | 2024 |
| R01NS115403 | Role of Protein Methylation in Cell Mitosis and Glioblastoma | 1 | 2024 |
| R01NS125775 | Protective role of Neuregulin-1 against cerebral malaria-induced neuronal injury and behavioral sequelae | 1 | 2024 |
| R21CA270998 | Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis | 1 | 2024 |
| R33CA252158 | Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles | 1 | 2024 |
| R35CA232093 | Systemic regulation of metastasis | 1 | 2024 |
| R35HL140014 | Vascular Growth and Regeneration | 1 | 2024 |
| R37CA218707 | Unmet needs for specific subsets of EGFR mutated lung cancer | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/grants?page=18